TRACON Pharmaceuticals' (NASDAQ:TCON) Charles Theuer presents to investors at the Proactive One2One Virtual Conference. TRACON is a clinical state biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related muscular degeneration, and fibrotic diseases.
TRACON Pharmaceuticals - Proactive One2One Virtual Event
Quick facts: TRACON Pharmaceuticals
Price: 4.85 USD
Market Cap: $63.94 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of TRACON Pharmaceuticals named herein, including the promotion by the Company of TRACON Pharmaceuticals in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE